Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota
Cells · 18.07.2023 · 12 (14) · 1882
DOI: 10.3390/cells12141882 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 18.07.2023. Verfasst von Minting Wen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Guangzhou University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Neoplasms, Microbiota. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural scientific research project of Guangzhou University, Guangzhou Municipal-school (college) Jointly Funded the Basic and Applied Basic Research Projects, Innovation and Entrepreneurship Training Programs for College Students in Guangzhou University.
Abstract (Originalsprache)
Cancer cells circumvent immune surveillance via diverse strategies. In accordance, a large number of complex studies of the immune system focusing on tumor cell recognition have revealed new insights and strategies developed, largely through major histocompatibility complexes (MHCs). As one of them, tumor-specific MHC-II expression (tsMHC-II) can facilitate immune surveillance to detect tumor antigens, and thereby has been used in immunotherapy, including superior cancer prognosis, clinical sensitivity to immune checkpoint inhibition (ICI) therapy and tumor-bearing rejection in mice. NK cells play a unique role in enhancing innate immune responses, accounting for part of the response including immunosurveillance and immunoregulation. NK cells are also capable of initiating the response of the adaptive immune system to cancer immunotherapy independent of cytotoxic T cells, clearly demonstrating a link between NK cell function and the efficacy of cancer immunotherapies. Eosinophils were shown to feature pleiotropic activities against a variety of solid tumor types, including direct interactions with tumor cells, and accessorily affect immunotherapeutic response through intricating cross-talk with lymphocytes. Additionally, microbial sequencing and reconstitution revealed that commensal microbiota might be involved in the modulation of cancer progression, including positive and negative regulatory bacteria. They may play functional roles in not only mucosal modulation, but also systemic immune responses. Here, we present a panorama of the cancer immune network mediated by MHCI/II molecules, immune cells and commensal microbiota and a discussion of prospective relevant intervening mechanisms involved in cancer immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science, Guangzhou University, Guangzhou 510006, China.
Förderung
- Intramural scientific research project of Guangzhou University
- Guangzhou Municipal-school (college) Jointly Funded the Basic and Applied Basic Research Projects
- Innovation and Entrepreneurship Training Programs for College Students in Guangzhou University
Zitieren
APA
Wen, M., Li, Y., Qin, X., Qin, B., & Wang, Q. (2023). Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota. Cells, 12(14), 1882. https://doi.org/10.3390/cells12141882
Vancouver
Wen M, Li Y, Qin X, Qin B, Wang Q. Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota. Cells. 2023;12(14):1882. doi:10.3390/cells12141882
BibTeX
@article{Wen2023,
author = {Wen, Minting and Li, Yingjing and Qin, Xiaonan and Qin, Bing and Wang, Qiong},
title = {Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota},
journal = {Cells},
year = {2023},
volume = {12},
number = {14},
pages = {1882},
doi = {10.3390/cells12141882}
}
EUVIMED